Company: RGBP
Filing Date: 2025-09-08
Form Type: 253G1
Source: 0001641172-25-026822
Chunk: 104

Company: Regen BioPharma Inc
Filing Date: 2025-09-08
Form: 253G1
Chunk 104
---
   |
| Preferred Stock, Value                                                                            |     |              |           - |   |     |               |           - |   |
| Additional Paid in capital                                                                        |     |              |  15,455,134 |   |     |               |  15,403,050 |   |
| Other Comprehensive Income                                                                        |     |              |    (204,847 | ) |     |               |    (204,847 | ) |
| Retained Earnings (Deficit)                                                                       |     |              | (20,932,504 | ) |     |               | (20,417,118 | ) |
| Total Stockholders’ Equity (Deficit)                                                              |     |              |  (5,679,043 | ) |     |               |  (5,217,372 | ) |
| TOTAL LIABILITIES & STOCKHOLDERS’ EQUITY (DEFICIT)                                                |     | $            |     191,416 |   |     | $             |     161,084 |   |

<div align='center'>The Accompanying Notes are an Integral Part of These Financial
Statements

All stock amounts have
been retroactively adjusted to reflect a 1 for 1500 reverse stock split of all issued series of stock effective as of March 6, 2023</div>

| 84 |

<div align='center'>REGEN BIOPHARMA , INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(unaudited)</div>

|                                                                                           |     | Quarter Ended 
 December      
 31, 2024      |      2024 |   |     | December 
 31, 2023 |      2023 |   |
|:------------------------------------------------------------------------------------------|:----|:--------------|----------:|:--|:----|:---------|----------:|:--|
| Net revenue:                                                                              |     |               |           |   |     |          |           |   |
| Revenues                                                                                  |     | $             |    31,640 |   |     |          |    31,640 |   |
| Revenues, Related Party                                                                   |     |               |    27,425 |   |     |          |    27,425 |   |
| Net revenue                                                                               |     |               |    59,065 |   |     |          |    59,065 |   |
| Operating expenses:                                                                       |     |               |           |